Results 161 to 170 of about 40,250 (264)

Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes: a Sentinel Distributed Database study. [PDF]

BMJ Open Diabetes Res Care
Kuzucan A, Tran V, Jones JT, Dutcher SK, Her M, Kempner ME, Lee JY, Mosholder A, Round KE, Toh S, Lyons JG.   +10 more
europepmc   +1 more source

Data‐driven cluster analysis of adults with prediabetes: Findings from the Japan diabetes prevention study

Journal of Diabetes Investigation, EarlyView.
Unsupervised clustering of 295 Japanese adults with impaired glucose tolerance identified three distinct prediabetes subtypes based on HbA1c, HOMA‐β, HOMA‐IR, and HDL‐cholesterol. These subtypes showed different risks of developing type 2 diabetes and varied responses to lifestyle intervention over 6 years.
Naoki Sakane, Kaoru Takahashi, Akiko Suganuma, Masayuki Domichi, Kazuyo Tsushita, Hideshi Kuzuya   +5 more
wiley   +1 more source

Bioactive Peptide-Enriched Requeson: A Functional Dairy Product From Whey Fermentation. [PDF]

Food Sci Nutr
Patlan-Velázquez LF, González-Olivares LG, García-Garibay M, Alatorre-Santamaría S, Gómez-Ruiz L, Rodríguez-Serrano G, Carrasco-Navarro U, Cruz-Guerrero A.   +7 more
europepmc   +1 more source

Impact of COVID‐19 restrictions and their relaxation on body composition and glycemic control in individuals with glucose intolerance in Japan: A single‐center observational study

Journal of Diabetes Investigation, EarlyView.
This study examined glycemic control, body composition, and lifestyle changes in 221 outpatients with glucose intolerance (GI) in Japan across the pre‐state of emergency (SOE), SOE, and post‐SOE periods. HbA1c increased despite body weight reduction, with progressive muscle loss.
Ami Kobayashi, Yamato Keidai, Takaaki Murakami, Ryo Tsukaguchi, Miharu Fujita, Keiko Wada, Daisuke Yabe   +6 more
wiley   +1 more source

Concomitant Use of DPP-4 Inhibitors May Prevent the Development of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Cohort Study. [PDF]

Clin Transl Sci
Koura Y, Mine K, Fujita S, Kawashiri T, Mori Y, Ueda M, Kaneko R, Hirota T, Uchida M, Kobayashi D.   +9 more
europepmc   +1 more source

Relative contributions of basal vs postprandial hyperglycaemia to overall glycaemic control in newly diagnosed Chinese adults with type 2 diabetes before and after 3 months' intensive glucose‐lowering therapy

Journal of Diabetes Investigation, EarlyView.
In newly‐diagnosed Chinese with T2D, Contribution of basal hyperglycaemia to hyperglycaemic exposure decreased substantially and the relative importance of postprandial hyperglycaemia increased markedly after 3 months glucose‐lowering therapy. Therapy should be re‐evaluated after initial treatment, and that a greater focus on limiting postprandial ...
Yixuan Sun, Yong Luo, Cong Xie, Karen L. Jones, Michael Horowitz, Christopher K. Rayner, Jianhua Ma, Tongzhi Wu   +7 more
wiley   +1 more source

The etiology of exudative cutaneous ulcers in a yaws-endemic community prior to receipt of antimicrobials is similar to that found in communities after mass treatment with azithromycin. [PDF]

mSphere
Brothwell JA, Toh E, Xing Y, Dong Q, Xu LH, Giacani L, Beiras CG, Mitjà O, Gao X, Spinola SM.   +9 more
europepmc   +1 more source

Effect of sodium–glucose cotransporter 2 inhibitors on heart failure readmission in older patients with diabetes: A Japanese claims‐based cohort study

Journal of Diabetes Investigation, EarlyView.
SGLT2 inhibitor use at discharge was associated with a reduced risk of heart failure readmission in elderly patients with diabetes, with no significant differences among individual agents. ABSTRACT Aims To evaluate the effect of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration at hospital discharge on heart failure (HF) readmission ...
Kazuya Hiura, Hirotaka Masuda, Masayuki Sakunami, Miki Yamashita   +3 more
wiley   +1 more source

Designing an implementation strategy to improve referral from general practice to a National Diabetes Prevention Programme using a Delphi survey with healthcare professionals and the Behaviour Change Wheel. [PDF]

BMJ Open
Haseldine C, O'Donoghue G, Kearney PM, Riordan F, Humphreys M, Kirby L, Mc Hugh SM.   +6 more
europepmc   +1 more source